Reducing systemic regulatory T cell levels or activity for treatment of disease and injury...

Anti-PD1 antibodies, activatable anti-PD1 antibodies, and methods of use thereof

KA Tipton, JW West, CM Chan - US Patent 10,513,558, 2019 - Google Patents
2016-10-26 Assigned to CYTOMX THERAPEUTICS, INC. reassignment CYTOMX
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
保存 引用 被引用数: 72 関連記事 全 4 バージョン キャッシュ

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereof

JW West, L Mei, SJ Moore, MTL Nguyen… - US Patent …, 2019 - Google Patents
2016-03-31 Assigned to CYTOMX THERAPEUTICS, INC. reassignment CYTOMX
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
保存 引用 被引用数: 64 関連記事 全 4 バージョン キャッシュ

Constructs having a SIRP-α domain or variant thereof

J Pons, L Deming, C Goodman, BJ Sim… - US Patent …, 2019 - Google Patents
2016-08-31 Assigned to Alexo Therapeutics Inc. reassignment Alexo Therapeutics Inc.
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
保存 引用 被引用数: 49 関連記事 全 4 バージョン キャッシュ
[Free GPT-4]
[PDF] googleapis.com

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

M Eisenbach-Schwartz, K Baruch… - US Patent …, 2018 - Google Patents
A pharmaceutical composition comprising an active agent that causes reduction of the level
of systemic immunosuppression in an individual for use in treating a disease, disorder …
保存 引用 被引用数: 32 関連記事 全 4 バージョン キャッシュ
[Free GPT-4]
[PDF] googleapis.com

Activatable anti-pdl1 antibodies, and methods of use thereof

R Humphrey, L Carman, M Will, B Zheng… - US Patent …, 2021 - Google Patents
US11168144B2 - Activatable anti-PDL1 antibodies, and methods of use thereof - Google
Patents US11168144B2 - Activatable anti-PDL1 antibodies, and methods of use thereof …
保存 引用 被引用数: 22 関連記事 全 4 バージョン キャッシュ

PD-1 binding proteins and methods of use thereof

B Bennett, PP Chamberlain, K Hariharan… - US Patent …, 2019 - Google Patents
US10428145B2 - PD-1 binding proteins and methods of use thereof - Google Patents
US10428145B2 - PD-1 binding proteins and methods of use thereof - Google Patents PD-1 …
保存 引用 被引用数: 28 関連記事 全 4 バージョン キャッシュ

Constructs having a SIRP-alpha domain or variant thereof

J Pons, BJ Sim, SE Kauder, H Wan… - US Patent 10,696,730, 2020 - Google Patents
The present disclosure features signal-regulatory protein α (SIRPα) polypeptides and
constructs that are useful, eg, to target a cell (eg, a cancer cell or a cell of the immune …
保存 引用 被引用数: 16 関連記事 全 4 バージョン キャッシュ

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

M Eisenbach-Schwartz, K Baruch… - US Patent …, 2020 - Google Patents
2017-11-29 Assigned to YEDA RESEARCH AND DEVELOPMENT CO., LTD. reassignment
YEDA RESEARCH AND DEVELOPMENT CO., LTD. ASSIGNMENT OF ASSIGNORS …
保存 引用 被引用数: 15 関連記事 全 4 バージョン キャッシュ

Methods of treating psoriasis using PD-1 binding antibodies

HH Chan, EM Hur, R Khattri, M Leung… - US Patent …, 2020 - Google Patents
US10751414B2 - Methods of treating psoriasis using PD-1 binding antibodies - Google
Patents US10751414B2 - Methods of treating psoriasis using PD-1 binding antibodies …
保存 引用 被引用数: 12 関連記事 全 4 バージョン キャッシュ

Methods of treating vitiligo using PD-1 binding antibodies

GE Ringheim - US Patent 10,766,958, 2020 - Google Patents
WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC [C@ H] 1O
[C@@ H](O)[C@ H](O)[C@@ H](O)[C@@ H] 1O WQZGKKKJIJFFOK-VFUOTHLCSA-N …
保存 引用 被引用数: 11 関連記事 全 3 バージョン キャッシュ